The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic Kiss1 system.
Roa. J J; Garcia-Galiano. D D; Varela. L L; Sánchez-Garrido. M A MA; Pineda. R R; Castellano. J M JM; Ruiz-Pino. F F; Romero. M M; Aguilar. E E; López. M M; Gaytan. F F; Diéguez. C C; Pinilla. L L; Tena-Sempere. M M
Key Findings
- Activating mTOR with leucine increases LH secretion and can partially reverse low hormone levels caused by food restriction
- Inhibiting central mTOR with rapamycin delays puberty, reduces LH and estradiol, and shrinks ovaries and uterus
- mTOR inhibition lowers hypothalamic Kiss1 expression, but the GnRH/LH axis still reacts to kisspeptin-10
Practical Outcomes
- For biohackers, the data suggest that chronic rapamycin use might suppress reproductive hormone production, which could affect fertility or hormone balance. Conversely, leucine supplementation could modestly boost LH, though relevance to adults is unclear. The findings reinforce that kisspeptin-10 remains effective even when mTOR is inhibited, so it could still be used to stimulate the gonadal axis if needed.
Summary
The study shows that the brain’s mTOR pathway helps start puberty by controlling the kisspeptin system. Turning mTOR on with the amino acid leucine boosts LH hormone release, while blocking mTOR with rapamycin delays puberty and lowers reproductive hormones in young female rats. Even when mTOR is blocked, the animals still respond to kisspeptin-10, meaning the basic GnRH system stays functional.
Abstract
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that operates as sensor of cellular energy status and effector for its coupling to cell growth and proliferation. At the hypothalamic arcuate nucleus, mTOR signaling has been recently proposed as transducer for leptin effects on energy homeostasis and food intake. However, whether central mTOR also participates in metabolic regulation of fertility remains unexplored. We provide herein evidence for the involvement of mTOR in the control of puberty onset and LH secretion, likely via modulation of hypothalamic expression of Kiss1. Acute activation of mTOR by l-leucine stimulated LH secretion in pubertal female rats, whereas chronic l-leucine infusion partially rescued the state of hypogonadotropism induced by food restriction. Conversely, blockade of central mTOR signaling by rapamycin caused inhibition of the gonadotropic axis at puberty, with significantly delayed vaginal opening, decreased LH and estradiol levels, and ovarian and uterine atrophy. Inactivation of mTOR also blunted the positive effects of leptin on puberty onset in food-restricted females. Yet the GnRH/LH system retained their ability to respond to ovariectomy and kisspeptin-10 after sustained blockade of mTOR, ruling out the possibility of unspecific disruption of GnRH function by rapamycin. Finally, mTOR inactivation evoked a significant decrease of Kiss1 expression at the hypothalamus, with dramatic suppression of Kiss1 mRNA levels at the arcuate nucleus. Altogether our results unveil the role of central mTOR signaling in the control of puberty onset and gonadotropin secretion, a phenomenon that involves the regulation of Kiss1 and may contribute to the functional coupling between energy balance and gonadal activation and function.
Study Information
pubmed
2009
2009-09-04T00:00:00.000Z
10.1210/en.2009-0096
218
37